Your browser doesn't support javascript.
loading
Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain.
Videla, Sebastián; Otero, Aurema; Martí, Sara; Domínguez, M Ángeles; Fabrellas, Nuria; Delgado-Hito, M Pilar; Cruz, Imma; Tebé, Cristian; Vinuesa, Teresa; Ardila, Fernando; Sancho, Marta; Fernández, Esteve; Figuerola, Montserrat; Ciruela, Francisco.
Afiliación
  • Videla S; Pharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  • Otero A; Clinical Research Support Unit (HUB-IDIBELL), Clinical Pharmacology Department, Bellvitge University Hospital, L'Hospitalet del Llobregat, 08907 Barcelona, Spain.
  • Martí S; Clinical Research Support Unit (HUB-IDIBELL), Clinical Pharmacology Department, Bellvitge University Hospital, L'Hospitalet del Llobregat, 08907 Barcelona, Spain.
  • Domínguez MÁ; Microbiology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  • Fabrellas N; Microbiology Department, Bellvitge University Hospital, L'Hospitalet del Llobregat, 08907 Barcelona, Spain.
  • Delgado-Hito MP; Consortium for Biomedical Research in Respiratory Diseases (CIBERES), 28029 Madrid, Spain.
  • Cruz I; Microbiology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  • Tebé C; Microbiology Department, Bellvitge University Hospital, L'Hospitalet del Llobregat, 08907 Barcelona, Spain.
  • Vinuesa T; Department of Public Health Nursing, Mental Health and Maternal and Childhood, School of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain.
  • Ardila F; Department of Fundamental and Medical-Surgical Nursing, School of Medicine and Health Sciences, GRIN-IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  • Sancho M; OSSMA (Oficina de Seguretat, Salut i Medi Ambient), University of Barcelona, 08028 Barcelona, Spain.
  • Fernández E; Biostatistical Unit, Department of Clinical Sciences, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  • Figuerola M; Microbiology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  • Ciruela F; UICEC-IDIBELL (Clinical Research Organization), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Int J Environ Res Public Health ; 18(12)2021 Jun 17.
Article en En | MEDLINE | ID: mdl-34204383
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pandemias / COVID-19 Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Int J Environ Res Public Health Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pandemias / COVID-19 Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Int J Environ Res Public Health Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Suiza